233 Summary and general discussion 103. Chen X-Y, Zhang J, Zhu J-S. The role of m6A RNA methylation in human cancer. Molecular Cancer. 2019;18(1):103. 104. Connell SP, O’Reilly E, Tuzova A, Webb M, Hurst R, Mills R, et al. Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer. The Prostate. 2020;80(7):547-58. 105. Albitar M, Zhang H, Charifa A, Ip A, Ma W, McCloskey J, et al. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors. Heliyon. 2023;9(5). 106. Thomas CE, Sexton W, Benson K, Sutphen R, Koomen J. Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiol Biomarkers Prev. 2010;19(4):953-9. 107. Behrouzi R, Barr CE, Crosbie EJ. HE4 as a Biomarker for Endometrial Cancer. Cancers (Basel). 2021;13(19). 108. Enroth S, Berggrund M, Lycke M, Lundberg M, Assarsson E, Olovsson M, et al. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer. Clin Proteomics. 2018;15:38. 109. Njoku K, Pierce A, Geary B, Campbell AE, Kelsall J, Reed R, et al. Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women. British Journal of Cancer. 2023;128(9):1723-32. 110. Gasparri R, Sedda G, Caminiti V, Maisonneuve P, Prisciandaro E, Spaggiari L. Urinary Biomarkers for Early Diagnosis of Lung Cancer. J Clin Med. 2021;10(8). 111. Barr CE, Njoku K, Owens GL, Crosbie EJ. Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women. Cancers (Basel). 2023;15(4). 112. Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discovery. 2022;12(1):31-46. 113. Bratulic S, Limeta A, Dabestani S, Birgisson H, Enblad G, Stålberg K, et al. Noninvasive detection of any-stage cancer using free glycosaminoglycans. Proceedings of the National Academy of Sciences. 2022;119(50):e2115328119. 114. Gatto F, Volpi N, Nilsson H, Nookaew I, Maruzzo M, Roma A, et al. Glycosaminoglycan Profiling in Patients’ Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma. Cell Reports. 2016;15(8):1822-36. 115. O’Flynn H, Ryan NAJ, Narine N, Shelton D, Rana D, Crosbie EJ. Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples. Nat Commun. 2021;12(1):952. 116. Lawrence R, Watters M, Davies CR, Pantel K, Lu Y-J. Circulating tumour cells for early detection of clinically relevant cancer. Nature Reviews Clinical Oncology. 2023. 117. van der Pol Y, Moldovan N, Verkuijlen S, Ramaker J, Boers D, Onstenk W, et al. The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation. Clinical Chemistry. 2022;68(6):803-13. 118. Bronkhorst AJ, Ungerer V, Oberhofer A, Gabriel S, Polatoglou E, Randeu H, et al. New Perspectives on the Importance of Cell-Free DNA Biology. Diagnostics (Basel). 2022;12(9). 119. Heitzer E, Auinger L, Speicher MR. Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living. Trends in Molecular Medicine. 2020;26(5):519-28. 8
RkJQdWJsaXNoZXIy MjY0ODMw